293 related articles for article (PubMed ID: 26910374)
1. Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas.
Cortes-Santiago N; Hossain MB; Gabrusiewicz K; Fan X; Gumin J; Marini FC; Alonso MM; Lang F; Yung WK; Fueyo J; Gomez-Manzano C
Oncotarget; 2016 Mar; 7(13):16146-57. PubMed ID: 26910374
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes.
Gabrusiewicz K; Liu D; Cortes-Santiago N; Hossain MB; Conrad CA; Aldape KD; Fuller GN; Marini FC; Alonso MM; Idoate MA; Gilbert MR; Fueyo J; Gomez-Manzano C
Oncotarget; 2014 Apr; 5(8):2208-20. PubMed ID: 24809734
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma.
Atanasov G; Hau HM; Dietel C; Benzing C; Krenzien F; Brandl A; Englisch JP; Wiltberger G; Schierle K; Robson SC; Reutzel-Selke A; Jonas S; Pascher A; Pratschke J; Schmelzle M
J Surg Oncol; 2016 Jul; 114(1):91-8. PubMed ID: 27111031
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas.
Lee OH; Xu J; Fueyo J; Alonso MM; Liu D; Martin V; Jiang H; Piao Y; Liu TJ; Gomez-Manzano C
Oncogene; 2008 Feb; 27(9):1310-4. PubMed ID: 17704802
[TBL] [Abstract][Full Text] [Related]
6. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
[TBL] [Abstract][Full Text] [Related]
7. IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.
Jiang S; Li Y; Lin T; Yuan L; Li Y; Wu S; Xia L; Shen H; Lu J
Cell Physiol Biochem; 2016; 40(5):1105-1116. PubMed ID: 27960151
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
9. Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype.
Liu D; Martin V; Fueyo J; Lee OH; Xu J; Cortes-Santiago N; Alonso MM; Aldape K; Colman H; Gomez-Manzano C
Oncotarget; 2010 Dec; 1(8):700-709. PubMed ID: 21321379
[TBL] [Abstract][Full Text] [Related]
10. Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection.
He YF; Wang CQ; Yu Y; Qian J; Song K; Sun QM; Zhou J
PLoS One; 2015; 10(11):e0143657. PubMed ID: 26599011
[TBL] [Abstract][Full Text] [Related]
11. Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.
Huang H; Lai JY; Do J; Liu D; Li L; Del Rosario J; Doppalapudi VR; Pirie-Shepherd S; Levin N; Bradshaw C; Woodnutt G; Lappe R; Bhat A
Clin Cancer Res; 2011 Mar; 17(5):1001-11. PubMed ID: 21233403
[TBL] [Abstract][Full Text] [Related]
12. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.
Matsubara T; Kanto T; Kuroda S; Yoshio S; Higashitani K; Kakita N; Miyazaki M; Sakakibara M; Hiramatsu N; Kasahara A; Tomimaru Y; Tomokuni A; Nagano H; Hayashi N; Takehara T
Hepatology; 2013 Apr; 57(4):1416-25. PubMed ID: 22815256
[TBL] [Abstract][Full Text] [Related]
13. Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model.
Nakazawa Y; Kawano S; Matsui J; Funahashi Y; Tohyama O; Muto H; Nakagawa T; Matsushima T
Cancer Sci; 2015 Feb; 106(2):201-7. PubMed ID: 25458359
[TBL] [Abstract][Full Text] [Related]
14. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
Shlamkovich T; Aharon L; Barton WA; Papo N
Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.
Coffelt SB; Tal AO; Scholz A; De Palma M; Patel S; Urbich C; Biswas SK; Murdoch C; Plate KH; Reiss Y; Lewis CE
Cancer Res; 2010 Jul; 70(13):5270-80. PubMed ID: 20530679
[TBL] [Abstract][Full Text] [Related]
16. Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2.
Lewis CE; De Palma M; Naldini L
Cancer Res; 2007 Sep; 67(18):8429-32. PubMed ID: 17875679
[TBL] [Abstract][Full Text] [Related]
17. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
[TBL] [Abstract][Full Text] [Related]
18. Adaptor Protein ShcD/
Tilak M; Alural B; Wismer SE; Brasher MI; New LA; Sheridan SD; Perlis RH; Coppolino MG; Lalonde J; Jones N
Mol Cancer Res; 2021 May; 19(5):757-770. PubMed ID: 33495401
[TBL] [Abstract][Full Text] [Related]
19. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
20. LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer.
Hou Y; Jia H; Cao Y; Zhang S; Zhang X; Wei P; Xie J; Dong W; Wang B
Life Sci; 2021 Feb; 267():118933. PubMed ID: 33359744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
